Readystate Asset Management LP Apellis Pharmaceuticals, Inc. Call Options Transaction History
Readystate Asset Management LP
- $3.27 Trillion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding APLS
# of Institutions
285Shares Held
125MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$299 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$297 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$289 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$246 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$234 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.67B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...